Drug rebates for insurers tied to higher costs for patients, especially the uninsured
Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower
Read more
Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower
Read moreAfter Kim Lauerman was diagnosed with ovarian cancer, doctors wanted to give her a drug that helps prevent infections and
Read more